Relay
3 known investors
Relay Therapeutics develops small-molecule therapeutics using its Dynamo platform, which combines experimental and computational methods to model protein motion and target proteins considered difficult to drug. Its pipeline focuses on precision oncology and genetic disease.
AI & Machine LearningBiotechDeep Tech
Investors Β· 3
Frequently asked questions
- What does Relay do?
- Relay Therapeutics develops small-molecule therapeutics using its Dynamo platform, which combines experimental and computational methods to model protein motion and target proteins considered difficult to drug. Its pipeline focuses on precision oncology and genetic disease.
- Who are Relay's investors?
- Relay's investors include EcoR1 Capital, Nextech Invest, SoftBank Vision Fund.